What Do Lung-RADS Categories Mean After Lung Screening?

Lung-RADS categories provide a standardized way to describe findings from low-dose CT lung cancer screening. The category helps communicate how concerning a lung nodule or another finding appears and what type of follow-up may be appropriate.

A Lung-RADS result does not diagnose lung cancer. It places the screening examination into a category based on factors such as whether a nodule is present, its size, its appearance, and whether it has changed since an earlier scan.

In simple terms:

• Lung-RADS 1 and 2 are generally considered negative screening results.
• Lung-RADS 3 means a finding is probably benign but should usually be checked again sooner.
• Lung-RADS 4A, 4B, and 4X indicate increasing levels of concern and may require additional evaluation.
• Lung-RADS 0 means the examination is incomplete or cannot yet be assigned a final category.

If your report contains a category you do not understand, do not assume the worst. Even a higher category is not the same as a cancer diagnosis. The next step is to review the full report with a physician who can consider your age, smoking history, previous imaging, symptoms, and overall health.

At Life Imaging, low-dose lung screening can identify nodules and other findings that may need monitoring or physician follow-up.

Lung-RADS stands for Lung Imaging Reporting and Data System. It is a structured reporting system developed for low-dose CT lung cancer screening.

Radiologists use Lung-RADS to:

• Describe the overall screening result
• Classify lung nodules according to their appearance and behavior
• Estimate how concerning a finding may be
• Recommend an appropriate next step
• Make reports more consistent between facilities and physicians
• Help screening programs track follow-up

Lung-RADS serves a role similar to other standardized imaging systems. Instead of every report using completely different language, the category gives patients and healthcare providers a common starting point.

Current reporting may use Lung-RADS version 2022. A review indexed by the National Library of Medicine explains that the 2022 version added guidance for several findings, including certain pulmonary cysts and airway nodules.

The version used can matter because criteria and recommendations have changed over time. Always follow the recommendation written in your individual report rather than relying on an older chart found online.

Low-dose CT can find very small lung nodules. Many of these nodules are not cancer.

A nodule may represent:

• Healed infection
• Inflammation
• Scar tissue
• A benign growth
• A lymph node near the lung surface
• Another noncancerous process
• Lung cancer

Finding a nodule is therefore only the beginning of the interpretation. The radiologist must consider its size, shape, density, location, and behavior over time.

Without a structured system, a phrase such as “small pulmonary nodule” can sound alarming even when the recommended action is simply routine annual screening.

Lung-RADS helps place the finding into context. It gives the physician a clearer sense of whether the scan appears negative, probably benign, suspicious, or very suspicious.

Research using data from the National Lung Screening Trial has treated Lung-RADS categories 1 and 2 as negative screening examinations and categories 3 and 4 as results requiring closer attention. Information about this research is available through the National Cancer Institute.

The category is not assigned based only on whether a nodule exists.

The radiologist may consider:

Lung-RADS 0 means the examination is incomplete.

This does not necessarily mean the scan was poorly performed. It often means the radiologist needs more information before assigning a final category.

Reasons may include:

• Previous chest CT images are needed for comparison.
• Additional images are required.
• A possible infection or inflammatory process needs short-term reassessment.
• The available examination does not provide enough information for final categorization.

If the report requests prior imaging, try to obtain the actual images rather than only an old written report. Comparing images directly can help show whether a finding is new, growing, or stable.

Your next step may be:

• Providing previous CT images
• Having additional imaging
• Completing a short-term follow-up scan
• Consulting your physician about a possible infection

Lung-RADS 0 is a temporary category. The goal is to gather enough information to assign a more definitive result.

Lung-RADS 1 is considered a negative screening result.

It generally means:

• No lung nodules were found, or
• Only findings considered definitively benign were seen

A Lung-RADS 1 result is reassuring, but it does not mean you can never develop lung cancer. Screening reflects what was visible at the time of the examination.

For eligible high-risk adults, the usual recommendation is to continue annual low-dose CT screening.

The Centers for Disease Control and Prevention recommends annual LDCT screening for people who meet established age and smoking-history criteria. A negative scan does not automatically end the screening schedule.

You should also seek medical care if new symptoms develop, even when the most recent screening result was negative.

Lung-RADS 2 is also generally considered a negative screening result.

It means the scan may contain a nodule or another finding with a benign appearance or behavior. The radiologist does not consider the finding suspicious enough to require earlier diagnostic evaluation based on the screening criteria.

Examples may include:

• Very small nodules
• Nodules with features strongly suggesting benignity
• Certain stable nodules
• Findings that have shown little or no concerning change

A category 2 result can still feel confusing because the report may mention a nodule. The presence of the word “nodule” does not automatically turn the screening into a positive cancer result.

The usual recommendation is to return to routine annual LDCT screening if you remain eligible.

Ask your physician whether the nodule needs any follow-up beyond the recommendation in the report. Avoid arranging extra scans independently, since unnecessary imaging adds radiation without necessarily improving care.

Lung-RADS 3 means a finding is probably benign.

The phrase “probably benign” can be difficult to process. It means the appearance is more likely to represent a noncancerous process, but the radiologist recommends checking it sooner than the next routine annual screening.

A follow-up low-dose CT is commonly recommended in approximately six months. The precise timing should come from your report and physician.

The purpose of the follow-up is to determine whether the finding:

• Remains stable
• Becomes smaller
• Disappears
• Changes in density
• Grows

A stable or resolving finding may later be assigned a lower category. Growth or another concerning change may lead to a higher category and additional evaluation.

National Cancer Institute research materials describe Lung-RADS 3 as a category generally managed with shorter-interval CT follow-up. The goal is careful monitoring, not immediate assumption of cancer.

Do not skip the recommended follow-up because the finding is “probably” benign. The follow-up is how stability or resolution is confirmed.

Lung-RADS 4A is considered suspicious.

The term “suspicious” means the finding deserves closer evaluation. It does not mean cancer has been confirmed.

A short-term follow-up low-dose CT, often in approximately three months, may be recommended. Depending on the nodule’s size and characteristics, a physician may also consider PET/CT or another form of evaluation.

The next step may depend on:

• Whether the nodule is solid or part-solid
• The size of the solid component
• Whether the nodule is new
• Whether it has grown
• The person’s smoking history
• Previous cancer history
• Other medical conditions

Short-interval imaging allows physicians to look for change. Infection and inflammation can sometimes produce findings that improve or resolve, while a persistent or growing finding may need additional investigation.

Follow the timing in your report rather than applying a general three-month rule without medical guidance.

Lung-RADS 4B means a finding is very suspicious.

This category usually calls for a more individualized diagnostic evaluation rather than waiting for routine annual screening.

Possible next steps may include:

• Diagnostic chest CT with or without contrast
• PET/CT
• Pulmonology consultation
• Thoracic surgery consultation
• Tissue sampling or biopsy
• Review by a multidisciplinary lung nodule team
• Comparison with all available previous imaging

The appropriate approach depends on the person’s health, the appearance of the finding, and whether they could safely undergo further procedures or treatment.

A category 4B result still does not prove that cancer is present. Infection, inflammation, and other benign conditions can sometimes resemble malignancy on imaging.

The category indicates that the finding is concerning enough to justify a prompt, organized evaluation.

Lung-RADS 4X is used when a category 3 or 4 finding has additional imaging features that increase concern.

The “X” signals that something beyond the basic size or density criteria makes the finding more suspicious.

Features may involve:

• Irregular or spiculated edges
• Concerning growth
• Associated lymph node changes
• Additional suspicious lung findings
• Other characteristics identified by the radiologist

Because category 4X reflects added concern, the next step should be individualized and discussed promptly with a physician.

Evaluation may include diagnostic imaging, PET/CT, specialist consultation, or tissue sampling. The report should provide a recommendation.

As with 4A and 4B, 4X is not a pathology result. A diagnosis of cancer requires an appropriate medical evaluation and, in many cases, tissue examination.

A Lung-RADS report may include an “S” modifier for a clinically significant or potentially significant finding unrelated to lung cancer.

A low-dose CT scan captures more than the lungs. Depending on the area included, the images may show parts of the heart, blood vessels, thyroid, upper abdomen, bones, or other structures.

Possible non-lung findings may involve:

• Coronary artery calcification
• Aortic enlargement
• Thyroid abnormalities
• Adrenal findings
• Bone changes
• Other visible abnormalities

The “S” modifier does not indicate a higher lung cancer category. It calls attention to something outside the primary lung screening assessment that may need medical review.

Ask your physician:

• What was found?
• Is it likely to be benign?
• Does it require another test?
• How quickly should it be evaluated?
• Has it appeared on previous imaging?

Incidental findings are common in CT imaging. Some require no action, while others deserve follow-up.

No.

A Lung-RADS category estimates the level of concern based on the scan. It is not a cancer diagnosis.

A higher category means the probability is greater than it is for a lower category and that closer evaluation is justified. It does not mean the finding will necessarily prove malignant.

Possible outcomes after follow-up include:

• The nodule disappears.
• The nodule becomes smaller.
• The nodule remains stable.
• The finding is linked to infection or inflammation.
• The nodule requires continued monitoring.
• A biopsy confirms a benign condition.
• A biopsy confirms cancer.

The purpose of Lung-RADS is to organize these next steps. It helps avoid treating every small nodule as an emergency while also reducing the chance that a concerning finding is forgotten.

A lung nodule is a small area that appears different from the surrounding lung tissue on imaging.

Nodules are common, especially among current and former smokers. Many are caused by conditions other than cancer.

Potential causes include:

• Previous infections
• Active inflammation
• Scar tissue
• Benign tumors
• Autoimmune conditions
• Environmental or occupational exposures
• Lung cancer

A nodule cannot be fully understood from the word alone. The radiologist considers its size, density, margins, location, and change over time.

A category 2 nodule and a category 4 nodule are not equivalent simply because both reports contain the word “nodule.”

Growth is one of the most useful clues when evaluating a lung nodule.

If a nodule has remained unchanged over a meaningful period, that stability can support a less concerning interpretation. A new or growing nodule may require closer attention.

When scheduling lung screening:

• Tell the center about previous chest CT scans.
• Ask the former facility how to obtain the images.
• Request digital image transfer if available.
• Bring reports, but understand that images may still be needed.
• Provide the dates and locations of previous scans.

A comparison can sometimes prevent unnecessary short-term follow-up. It can also reveal a change that might otherwise be missed.

The appropriate next step depends on the category and the complete report.

No. Lung-RADS is specifically designed for low-dose CT lung cancer screening.

A diagnostic CT performed because of symptoms or a known medical concern may use different reporting and follow-up systems.

Nodules discovered incidentally on an unrelated CT may also be managed under different clinical guidelines.

This distinction matters. A person should not take a Lung-RADS chart from the internet and apply it independently to a diagnostic CT report.

Ask the interpreting facility or your physician which guideline applies to your examination.

A standardized system improves consistency, but it does not replace professional judgment.

Limitations include:

• A category cannot determine with certainty whether a nodule is cancerous.
• Nodules can grow at different rates.
• Very slow-growing cancers may remain stable over short periods.
• Infection can resemble cancer.
• Measurements may vary slightly between scans.
• Image quality can affect characterization.
• Individual health factors may justify a different follow-up plan.

Research available through the National Library of Medicine has examined the limitations of relying on short-term stability for certain nodules. This is one reason the full clinical context and radiologist’s recommendation matter.

The CDC recommends annual low-dose CT screening for adults who:

• Are between 50 and 80 years old
• Have at least a 20 pack-year smoking history
• Currently smoke or quit within the past 15 years

These recommendations are designed for people without symptoms who have an elevated risk because of their smoking history.

Life Imaging also discusses risk factors and candidate considerations on its lung screening service page.

If you have persistent coughing, coughing up blood, unexplained weight loss, chest pain, or worsening shortness of breath, speak with a physician. Symptomatic patients may need diagnostic evaluation rather than routine screening.

Life Imaging’s lung screening uses low-dose CT imaging to evaluate the lungs for nodules and other abnormalities.

The appointment generally involves:

If the report includes a Lung-RADS category, use it as a guide to the recommended next step. The category should be reviewed with a qualified healthcare provider.

When the report feels overwhelming, begin with a few direct questions:

• What is my Lung-RADS category?
• What specific finding determined that category?
• How large is the nodule?
• Is it new, stable, or growing?
• Do you have my previous images for comparison?
• When should I have my next scan?
• Do I need a diagnostic CT or PET/CT?
• Should I see a pulmonologist?
• Was anything found outside the lungs?
• Who will coordinate the follow-up?

You do not need to understand every radiology term before speaking with your physician. Focus first on what was found and what needs to happen next.

Life Imaging provides low-dose preventive lung screening for people who want a clearer view of their lung health before symptoms develop.

Patients receive:

• A quick, noninvasive CT examination
• Low-dose imaging
• No sedation required
• No standard recovery period
• Professional image interpretation
• A written results report
• Information that can be shared with a physician

Explore our services at Life Imaging or visit Life Imaging’s Deerfield Beach, Life Imaging’s Miami center, Life Imaging Jupiter center, or the Orlando center.

Frequently Asked Questions

Treat the Category as a Next-Step Guide

Lung-RADS categories are designed to turn a complicated CT report into a clearer follow-up pathway.

A low category is generally reassuring. A category 3 finding usually requires monitoring. A category 4 finding deserves prompt evaluation, but it still does not equal a cancer diagnosis.

The most important step is not memorizing every category. It is knowing what your report recommends and making sure that follow-up happens at the right time.

If you are considering preventive lung screening, contact Life Imaging today. You can also request an appointment or call 954-834-6362.